The most common side effects of retatrutide among participants were similar to those of other GLP-1 medications: nausea diarrhea constipation vomiting upper respiratory tract infection A small number of participants also experienced dysesthesia and urinary tract infections (UTIs)
These findings have important clinical implications, as they suggest that GLP-1 analogs could be a viable treatment option for patients with MSH, PSW, or other forms of obesity resulting from MC4R deficiencies
Partial BPI of the lower trunk In this type of injury, the lower parts of the brachial plexus that control the hand and fingers are injured
I take the medication on Monday, and felt no hunger pangs until Saturday
Participants were negative for HLA27 and none had clinical signs of spondyloarthritis or psoriasis
Mice (2035 g) were maintained in plastic ventilated cages in a pathogen-free environment (12 h/12 h light/dark cycle, 2124C) at Institut Pasteur de Lille, and had ad libitum access to water and food